Preveceutical Medical Stock Performance
| PRVCF Stock | USD 0.02 0 9.76% |
PreveCeutical Medical holds a performance score of 10 on a scale of zero to a hundred. The company holds a Beta of -3.85, which implies a somewhat significant risk relative to the market. As returns on the market increase, returns on owning PreveCeutical Medical are expected to decrease by larger amounts. On the other hand, during market turmoil, PreveCeutical Medical is expected to outperform it. Use PreveCeutical Medical jensen alpha, semi variance, day typical price, as well as the relationship between the maximum drawdown and accumulation distribution , to analyze future returns on PreveCeutical Medical.
Risk-Adjusted Performance
10 of 100
Weak | Strong |
OK
Compared to the overall equity markets, risk-adjusted returns on investments in PreveCeutical Medical are ranked lower than 10 (%) of all global equities and portfolios over the last 90 days. Despite nearly weak fundamental indicators, PreveCeutical Medical reported solid returns over the last few months and may actually be approaching a breakup point. ...more
| Begin Period Cash Flow | 156.4 K | |
| Total Cashflows From Investing Activities | -52.7 K |
PreveCeutical |
PreveCeutical Medical Relative Risk vs. Return Landscape
If you would invest 1.09 in PreveCeutical Medical on October 27, 2024 and sell it today you would earn a total of 0.76 from holding PreveCeutical Medical or generate 69.72% return on investment over 90 days. PreveCeutical Medical is currently producing 1.7977% returns and takes up 13.711% volatility of returns over 90 trading days. Put another way, most equities are less risky on the basis of their return distribution than PreveCeutical, and majority of traded equity instruments are likely to generate higher returns over the next 90 trading days. Expected Return |
| Risk |
PreveCeutical Medical Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for PreveCeutical Medical's investment risk. Standard deviation is the most common way to measure market volatility of otc stocks, such as PreveCeutical Medical, and traders can use it to determine the average amount a PreveCeutical Medical's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = 0.1311
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | PRVCF | |||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns |
Estimated Market Risk
| 13.71 actual daily | 96 96% of assets are less volatile |
Expected Return
| 1.8 actual daily | 35 65% of assets have higher returns |
Risk-Adjusted Return
| 0.13 actual daily | 10 90% of assets perform better |
Based on monthly moving average PreveCeutical Medical is performing at about 10% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of PreveCeutical Medical by adding it to a well-diversified portfolio.
PreveCeutical Medical Fundamentals Growth
PreveCeutical OTC Stock prices reflect investors' perceptions of the future prospects and financial health of PreveCeutical Medical, and PreveCeutical Medical fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on PreveCeutical OTC Stock performance.
| Return On Asset | -3.31 | |||
| Current Valuation | 12.06 M | |||
| Shares Outstanding | 523.3 M | |||
| Price To Sales | 3,902 X | |||
| EBITDA | (1.28 M) | |||
| Cash And Equivalents | 2.64 K | |||
| Total Debt | 1.68 M | |||
| Debt To Equity | 347.60 % | |||
| Book Value Per Share | (0.01) X | |||
| Cash Flow From Operations | (426.39 K) | |||
| Earnings Per Share | (0) X | |||
| Total Asset | 161.2 K | |||
About PreveCeutical Medical Performance
By analyzing PreveCeutical Medical's fundamental ratios, stakeholders can gain valuable insights into PreveCeutical Medical's financial health, operational efficiency, and overall profitability, helping them make informed investment and management decisions. For instance, if PreveCeutical Medical has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if PreveCeutical Medical has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements.
PreveCeutical Medical Inc., a health sciences company, engages in the development of options for preventive and curative therapies utilizing organic and nature identical products. PreveCeutical Medical Inc. is headquartered in Vancouver, Canada. Preveceutical Medical operates under Biotechnology classification in the United States and is traded on OTC Exchange.Things to note about PreveCeutical Medical performance evaluation
Checking the ongoing alerts about PreveCeutical Medical for important developments is a great way to find new opportunities for your next move. OTC Stock alerts and notifications screener for PreveCeutical Medical help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| PreveCeutical Medical is way too risky over 90 days horizon | |
| PreveCeutical Medical has some characteristics of a very speculative penny stock | |
| PreveCeutical Medical appears to be risky and price may revert if volatility continues | |
| PreveCeutical Medical has high likelihood to experience some financial distress in the next 2 years | |
| PreveCeutical Medical has high financial leverage indicating that it may have difficulties to generate enough cash to satisfy its financial obligations | |
| PreveCeutical Medical has accumulated 1.68 M in total debt with debt to equity ratio (D/E) of 347.6, indicating the company may have difficulties to generate enough cash to satisfy its financial obligations. PreveCeutical Medical has a current ratio of 0.02, indicating that it has a negative working capital and may not be able to pay financial obligations in time and when they become due. Debt can assist PreveCeutical Medical until it has trouble settling it off, either with new capital or with free cash flow. So, PreveCeutical Medical's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like PreveCeutical Medical sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for PreveCeutical to invest in growth at high rates of return. When we think about PreveCeutical Medical's use of debt, we should always consider it together with cash and equity. | |
| Net Loss for the year was (1.73 M) with profit before overhead, payroll, taxes, and interest of 2.25 K. | |
| PreveCeutical Medical has accumulated about 2.64 K in cash with (426.39 K) of positive cash flow from operations. | |
| Roughly 24.0% of PreveCeutical Medical outstanding shares are owned by corporate insiders |
- Analyzing PreveCeutical Medical's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether PreveCeutical Medical's stock is overvalued or undervalued compared to its peers.
- Examining PreveCeutical Medical's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating PreveCeutical Medical's management team can have a significant impact on its success or failure. Reviewing the track record and experience of PreveCeutical Medical's management team can help you assess the OTC Stock's leadership.
- Pay attention to analyst opinions and ratings of PreveCeutical Medical's otc stock. These opinions can provide insight into PreveCeutical Medical's potential for growth and whether the stock is currently undervalued or overvalued.
Complementary Tools for PreveCeutical OTC Stock analysis
When running PreveCeutical Medical's price analysis, check to measure PreveCeutical Medical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy PreveCeutical Medical is operating at the current time. Most of PreveCeutical Medical's value examination focuses on studying past and present price action to predict the probability of PreveCeutical Medical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move PreveCeutical Medical's price. Additionally, you may evaluate how the addition of PreveCeutical Medical to your portfolios can decrease your overall portfolio volatility.
| Equity Valuation Check real value of public entities based on technical and fundamental data | |
| Technical Analysis Check basic technical indicators and analysis based on most latest market data | |
| Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk | |
| USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA | |
| Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
| Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios | |
| Transaction History View history of all your transactions and understand their impact on performance |